Google
DXR 株価分析 — Daxor Corporation (Healthcare >> Medical Instruments & Supplies)
DXR に関するよくある質問
DXRのPER（株価収益率）は？
Daxor Corporation（DXR）は現在PER 4.54倍で取引されています。
DXRのROE（自己資本利益率）は？
Daxor CorporationのROEは19.98%です。
DXRの配当利回りは？
Daxor Corporationの配当利回りは0.00%です。
DXRの品質スコア（Quality Score）は？
当社のAIはDXRの総合財務品質を100点中100点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
DXRは今が買い時ですか？
当社AIのタイミングスコアは100点中5点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
DXRはどのセクターに属しますか？
Daxor CorporationはHealthcare >> Medical Instruments & Suppliesセクターに分類されます（NASDAQ市場）
DXR AI Analysis Summary
Our AI summary for DXR: Daxor Corporation (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 4.54, ROE of 19.98%, a dividend yield of 0.00%. Its financial Quality Score stands at 100/100 — fundamentals stronger than most of the market. The AI Timing Score is 5/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 10.50
Price
-0.03
(-0.28%)
Day Change
|
|
|---|
DXR, ファンダメンタルスコアはexcellent ( ファンダメンタル = 100) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Excellent
- Reason
-
Company financial health is Excellent from almost all quality indicators
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is good , ...
| Deepscope 分析 |
|
58% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1237
|
| Magic Formula Rank by ROE |
1237
|
| Magic Formula Rank by ROIC |
1522
|
| Price | 10.50 |
| PBV / Sector |
1.16 / 3.37
GREAT
|
| Earning Per Share | 1.84 |
| PE / Sector |
4.54 / 44.25
GREAT
|
| PEG or PE/Growth / Sector |
-1.26 / -1.35
|
| Average 1M Daily Value |
0.02 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
77% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:45 |
| Symbol | DXR |
| Name | DAXOR CORPORATION |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NASDAQ |
| Listed Shares | 5.84 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 53.13 / 16,159.14 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 109 Meco Lane, Oak Ridge, TN, United States, 37830
Phone: 865 425 0555
Website: https://www.daxor.com
Description: Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
